United Health Products Inc (UEEC)

[rodman]

Here is another summary of the progress of UEEC......

http://unitedhealthproductsinc.com/Assets/SeeThruEquity1.0.pdf

UHP has now sought FDA approval since March 21, 2017

Industry competition
UEEC operates in a highly competitive healthcare industry. The company is particularly focused on the disposable medical supply
market in the United States. This market is competitive and is dominated by large companies including Baxter International,
Bristol-Myers Squibb Company, Johnson & Johnson and 3M Company. These companies have greater access to financial
resources, more established brand recognition, and a large sales distribution network. Additionally, they have access to more
advanced research and development facilities, and more resources to dedicate to complying with federal and state regulations.
UEEC does focus on a subset of this market – hemostatic products. The company’s hemostatic products include gauzes, gels,
bandages and powders. Management believes the market for its hemostatic products is characterized by less intense competition,
comprised of smaller, privately-held companies and Johnson & Johnson, which manufactures Surgicel®. UHP has come a long way!